Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Omniab Inc (OABI)

Omniab Inc (OABI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Omniab Inc 5980 Horton Street Suite 600 Emeryville CA 94608 USA

www.omniab.com Employees: 114 P: 510-250-7800

Sector:

Medical

Description:

OmniAb Inc. discovery platform provides pharmaceutical industry partners access to the diverse antibody repertoires and screening technologies to enable discovery of next-generation therapeutics. OmniAb Inc., formerly known as Avista Public Acquisition Corp. II, is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 272,075
Enterprise Value, $K 244,475
Shares Outstanding, K 143,955
Float, K 131,575
% Float 91.40%
Short Interest, K 5,789
Short Float 4.02%
Days to Cover 16.04
Short Volume Ratio 0.57
% of Insider Shareholders 8.60%
% of Institutional Shareholders 72.08%

Financials:

Annual Sales, $ 26,390 K
Annual Net Income, $ -62,030 K
Last Quarter Sales, $ 2,240 K
Last Quarter Net Income, $ -16,530 K
EBIT, $ -53,340 K
EBITDA, $ -31,250 K

Growth:

1-Year Return -42.65%
3-Year Return -42.38%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/04/25
Next Earnings Date 05/14/26
Earnings Per Share ttm -0.58
EPS Growth vs. Prev Qtr 21.43%
EPS Growth vs. Prev Year 8.33%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

OABI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -23.99%
Return-on-Assets % -21.37%
Profit Margin % -235.05%
Debt/Equity 0.00
Price/Sales 15.42
Price/Cash Flow N/A
Price/Book 1.08
Book Value/Share 1.93
Interest Coverage -1.52
60-Month Beta 0.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar